Researchers have found in a new study that the novel Lesifter device shows encouraging early efficacy and a favorable safety profile in reducing stroke risk among patients with atrial ...

On the first day of the 2016 CardioStim sessions, I am happy to report a "positive" study on percutaneous left atrial appendage closure [1]. Notice I did not write Watchman. In Europe, the majority of ...

CHICAGO -- For patients at high risk of stroke who underwent catheter-based atrial fibrillation ablation, left atrial appendage closure led to less bleeding compared with oral anticoagulation, the ...

First and only steerable delivery system designed to help seal the left atrial appendage (LAA) in people with atrial fibrillation who are at an increased risk of stroke Now available in the U.S., ...

Left atrial appendage occlusion might be a treatment option for patients on dialysis with atrial fibrillation. Left atrial appendage occlusion (LAAO) placement is associated with a reduced risk for ...

Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...

The current bias of medicine is strong. When we are in doubt, when evidence is sparse, doctors do more, not less. Internists prescribe, cardiologists implant, surgeons cut. We know what we know. So it ...

The global left atrial appendage closure (LAAC) devices market is projected to register a robust growth from 2025 to 2033.

Atrial fibrillation is one of the most common kinds of arrhythmia, causing the heart not to contract properly in order to ...

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and remains a significant contributor to morbidity and mortality worldwide. A central focus of current research is the left ...

The MarketWatch News Department was not involved in the creation of this content. New partner reinforces confidence in the company's progress and future potential. NASHUA, N.H., Aug. 12, 2025 ...

Erlanger Cardiology completed the first in Chattanooga concomitant left atrial appendage closure (LAAC) and cardiac ablation for atrial fibrillation (AFib) on Nov. 23. Officials said, "This is an ...